- Home
- FLL vs PBYI Comparison
FLL vs PBYI Comparison
Compare FLL & PBYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FLL | PBYI |
|---|---|---|
| Founded | 1987 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 90.3M | 263.4M |
| IPO Year | 1993 | N/A |
Fundamental Metrics
Financial Performance| Metric | FLL | PBYI |
|---|---|---|
| Price | $2.66 | $5.86 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | $5.00 | ★ $7.00 |
| AVG Volume (30 Days) | 195.8K | ★ 381.0K |
| Earning Date | 11-06-2025 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 59.87 |
| EPS | N/A | ★ 0.74 |
| Revenue | ★ $299,916,000.00 | $211,995,000.00 |
| Revenue This Year | $4.87 | N/A |
| Revenue Next Year | $7.48 | N/A |
| P/E Ratio | ★ N/A | $7.99 |
| Revenue Growth | ★ 7.45 | N/A |
| 52 Week Low | $2.25 | $2.58 |
| 52 Week High | $5.59 | $6.27 |
Technical Indicators
Market Signals| Indicator | FLL | PBYI |
|---|---|---|
| Relative Strength Index (RSI) | 47.93 | 54.99 |
| Support Level | $2.51 | $5.64 |
| Resistance Level | $2.69 | $6.27 |
| Average True Range (ATR) | 0.14 | 0.24 |
| MACD | -0.03 | -0.02 |
| Stochastic Oscillator | 23.13 | 43.04 |
Price Performance
Historical ComparisonAbout FLL Full House Resorts Inc.
Full House Resorts Inc owns, operates, develops, manages, and invests in casinos and related hospitality and entertainment facilities. It offers facilities related to gaming, hotel, dining, entertainment, retail, and other amenities. The group's reportable segments are Midwest & South, West, and Contracted Sports Wagering, It generates the majority of its revenue from the Midwest & South segment which includes Silver Slipper Casino and Hotel, Rising Star Casino Resort, and American Place. The west segment includes Grand Lodge, Stockman's Casino, Bronco Billy's Casino and Hotel, and Chamonix Casino Hotel. The Contracted Sports Wagering segment comprises on-site and online sports wagering skins.
About PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis resulting into apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.